A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)

NCT00735436 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Study enrollment was halted due to slow accrual.

Conditions

Malignant Glioma
Glioblastoma Multiforme
Gliosarcoma

Interventions

DRUG: Gliadel/Avastin/CPT-11

Sponsor

Duke University

Collaborators

[object Object]
[object Object]